Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Should Create Cost-Effectiveness Group To Advise CMS – NEJM Editorial

This article was originally published in The Gray Sheet

Executive Summary

The U.S. government should establish an institute similar to the UK's National Institute for Clinical Excellence to help CMS apply cost-effectiveness criteria to coverage and payment decisions, according to an editorial in the Oct. 6 New England Journal of Medicine

You may also be interested in...



Medicare Experts Mull Idea Of U.S. Comparative Effectiveness Review Agency

Impressed by the success of the UK's comparative effectiveness health care agency NICE, Medicare payment expert Gail Wilensky is leading a push for a similar body in the United States - and at least one major stakeholder, Johnson & Johnson, appears willing to contemplate the idea

Medicare Experts Mull Idea Of U.S. Comparative Effectiveness Review Agency

Impressed by the success of the UK's comparative effectiveness health care agency NICE, Medicare payment expert Gail Wilensky is leading a push for a similar body in the United States - and at least one major stakeholder, Johnson & Johnson, appears willing to contemplate the idea

CRT-D Cost-Effectiveness Disputed; JACC Editorial Says More Studies Needed

Additional head-to-head trials are necessary to assess whether the benefit of cardiac resynchronization therapy with defibrillation (CRT-D) justifies its high cost, according to Mark Hlatky, MD, Stanford University

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel